NCAM1 and Alzheimer disease: This study provides novel insights into the spatiotemporal regulation of ES-GluN2B and PSA-NCAM in AD mouse models and normal aging, highlighting key molecular alterations associated with synaptic dysfunction and cognitive decline in AD.